Share your views: Consultation on a proposal to control 2-methyl-AP-237 and related substances under the Controlled Drugs and Substances Act
Current status: Closed
This consultation ran from August 26, 2023, to September 25, 2023.
Health Canada consulted on a proposal to control 2-methyl-AP-237 and related substances under the Controlled Drugs and Substances Act. Read the Notice of Intent for more details on the proposal.
Under this proposal, 2-methyl-AP-237, a synthetic opioid, and related substances would be scheduled as controlled substances under the Controlled Drugs and Substances Act and regulated as narcotics under the Narcotic Control Regulations. In March 2023, the United Nations Commission on Narcotic Drugs voted in favour of controlling 2-methyl-AP-237 internationally.
Who was the focus of this consultation
Health Canada consulted with:
- Licensed dealers of controlled substances;
- Law enforcement;
- Researchers working with controlled substances;
- Interested members of the public.
- Controlled Substances and Precursor Chemicals
- Controlled Drugs and Substances Act
- Narcotic Control Regulations
Office of Legislative and Regulatory Affairs
Controlled Substances Directorate
- Date modified: